Repligen Corp [RGEN] stock prices are up 0.47% to $166.36 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RGEN shares have gain 5.23% over the last week, with a monthly amount glided 2.37%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on October 01, 2025, when HSBC Securities initiated its Buy rating and assigned the stock a price target of $150. Previously, Evercore ISI upgraded its rating to Outperform on September 22, 2025, and kept the price target unchanged to $155. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $150 on June 24, 2025. Wolfe Research upgraded its rating to a Outperform but $160 remained the price target by the analyst firm on April 29, 2025. Evercore ISI started tracking with a In-line rating for this stock on March 18, 2025, and assigned it a price target of $155. In a note dated February 10, 2025, TD Cowen initiated an Buy rating and provided a target price of $200 on this stock.
The stock price of Repligen Corp [RGEN] has been fluctuating between $102.96 and $182.52 over the past year. Currently, Wall Street analysts expect the stock to reach $178.33 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $166.36 at the most recent close of the market. An investor can expect a potential return of 7.2% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
The Repligen Corp [NASDAQ:RGEN] reported sales of 707.89M for trailing twelve months, representing a surge of 21.91%. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 163.60 points at the first support level, and at 160.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 168.04, and for the 2nd resistance point, it is at 169.73.
Ratios To Look Out For
It’s worth pointing out that Repligen Corp [NASDAQ:RGEN]’s Current Ratio is 8.36. In addition, the Quick Ratio stands at 7.14 and the Cash Ratio stands at 5.71. Considering the valuation of this stock, the price to sales ratio is 13.23, the price to book ratio is 4.49 and price to earnings (TTM) ratio is 6473.15.
Transactions by insiders
Recent insider trading involved DAWES KAREN A, Director, that happened on Dec 17 ’25 when 275.0 shares were sold. Director, DAWES KAREN A completed a deal on Dec 17 ’25 to buy 275.0 shares. Meanwhile, Chief Executive Officer Loeillot Olivier sold 7041.0 shares on Nov 25 ’25.
